Chelsea Therapeutics (CHTP) Reports Q4 Loss of 20c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts CHTP Hot Sheet
Join SI Premium – FREE
Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) reported Q4 EPS of ($0.20), $0.12 better than the analyst estimate of ($0.32).
For earnings history and earnings-related data on Chelsea Therapeutics International Ltd. (CHTP) click here.
For earnings history and earnings-related data on Chelsea Therapeutics International Ltd. (CHTP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JetBlue shares jump on Q3 results and 2027 outlook
- German American Bancorp (GABC) Tops Q3 EPS by 2c
- Nucor (NUE) Reports In-Line Q3 EPS; offers outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
